Acknowledgements
We would like to thank Editage (www.editage.com) for English language
editing.
References
1. Walkey AJ, Goligher EC, Del Sorbo L, et al. Low Tidal Volume versus
Non-Volume-Limited Strategies for Patients with Acute Respiratory
Distress Syndrome. A Systematic Review and Meta-Analysis. Ann Am
Thorac Soc. 2017;14(Supplement_4):S271-S279.
2. Wang C, Wang X, Chi C, et al. Lung ventilation strategies for acute
respiratory distress syndrome: a systematic review and network
meta-analysis. Sci Rep. 2016;6:22855.
3. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler
A. Ventilation with lower tidal volumes as compared with traditional
tidal volumes for acute lung injury and the acute respiratory distress
syndrome. N Engl J Med. 2000;342(18):1301-1308.
4. Rimensberger PC, Cheifetz IM. Ventilatory support in children with
pediatric acute respiratory distress syndrome: proceedings from the
Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit
Care Med. 2015;16(5 Suppl 1):S51-60.
5. Wong JJM, Lee SW, Tan HL, et al. Lung-Protective Mechanical
Ventilation Strategies in Pediatric Acute Respiratory Distress Syndrome.Pediatr Crit Care Med. 2020;21(8):720-728.
6. Ballabh P. Pathogenesis and prevention of intraventricular
hemorrhage. Clin Perinatol. 2014;41(1):47-67.
7. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution
of subependymal and intraventricular hemorrhage: a study of infants with
birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529-534.
8. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing
enterocolitis. Therapeutic decisions based upon clinical staging.Ann Surg. 1978;187(1):1-7.
9. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for
assessing risk of bias in randomised trials. Bmj. 2019;366:l4898.
10. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for
assessing risk of bias in non-randomised studies of interventions.Bmj. 2016;355:i4919.
11. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the
quality of evidence–imprecision. J Clin Epidemiol.2011;64(12):1283-1293.
12. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on
rating quality of evidence and strength of recommendations. Bmj.2008;336(7650):924-926.
13. Schunemann HJ, Cuello C, Akl EA, et al. GRADE guidelines: 18. How
ROBINS-I and other tools to assess risk of bias in nonrandomized studies
should be used to rate the certainty of a body of evidence. J Clin
Epidemiol. 2019;111:105-114.
14. Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive
hypercapnia in preterm infants. Pediatrics. 1999;104(5 Pt
1):1082-1088.
15. Carlo WA, Stark AR, Wright LL, et al. Minimal ventilation to prevent
bronchopulmonary dysplasia in extremely-low-birth-weight infants.J Pediatr. 2002;141(3):370-374.
16. Thome UH, Carroll W, Wu TJ, et al. Outcome of extremely preterm
infants randomized at birth to different PaCO2 targets during the first
seven days of life. Biol Neonate. 2006;90(4):218-225.
17. Thome UH, Genzel-Boroviczeny O, Bohnhorst B, et al. Permissive
hypercapnia in extremely low birthweight infants (PHELBI): a randomised
controlled multicentre trial. The Lancet Respiratory Medicine.2015;3(7):534-543.
18. Thome UH, Genzel-Boroviczeny O, Bohnhorst B, et al.
Neurodevelopmental outcomes of extremely low birthweight infants
randomised to different PCO2 targets: the PHELBI follow-up study.Arch Dis Child Fetal Neonatal Ed. 2017;102(5):F376-F382.
19. Hagen EW, Sadek-Badawi M, Carlton DP, Palta M. Permissive
hypercapnia and risk for brain injury and developmental impairment.Pediatrics. 2008;122(3):e583-589.
20. Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety,
reliability, and validity of a physiologic definition of
bronchopulmonary dysplasia. J Perinatol. 2003;23(6):451-456.
21. Ma J, Ye H. Effects of permissive hypercapnia on pulmonary and
neurodevelopmental sequelae in extremely low birth weight infants: a
meta-analysis. Springerplus. 2016;5(1):764.
22. Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary
Dysplasia: Executive Summary of a Workshop. J Pediatr.2018;197:300-308.
23. Woodgate PG, Davies MW. Permissive hypercapnia for the prevention of
morbidity and mortality in mechanically ventilated newborn infants.Cochrane Database Syst Rev. 2001(2):CD002061.
24. Isayama T, Lee SK, Yang J, et al. Revisiting the Definition of
Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory
Support for Preterm Neonates. JAMA Pediatr. 2017;171(3):271-279.
25. Brew N, Walker D, Wong FY. Cerebral vascular regulation and brain
injury in preterm infants. Am J Physiol Regul Integr Comp
Physiol. 2014;306(11):R773-786.
26. Wallin LA, Rosenfeld CR, Laptook AR, et al. Neonatal intracranial
hemorrhage: II. Risk factor analysis in an inborn population.Early Hum Dev. 1990;23(2):129-137.
27. Greisen G. Autoregulation of cerebral blood flow in newborn babies.Early Hum Dev. 2005;81(5):423-428.
28. Noori S, Anderson M, Soleymani S, Seri I. Effect of carbon dioxide
on cerebral blood flow velocity in preterm infants during postnatal
transition. Acta Paediatr. 2014;103(8):e334-339.
29. Ainslie PN, Duffin J. Integration of cerebrovascular CO2 reactivity
and chemoreflex control of breathing: mechanisms of regulation,
measurement, and interpretation. Am J Physiol Regul Integr Comp
Physiol. 2009;296(5):R1473-1495.
30. Kaiser JR, Gauss CH, Pont MM, Williams DK. Hypercapnia during the
first 3 days of life is associated with severe intraventricular
hemorrhage in very low birth weight infants. J Perinatol.2006;26(5):279-285.
31. Hoffman SB, Lakhani A, Viscardi RM. The association between carbon
dioxide, cerebral blood flow, and autoregulation in the premature
infant. J Perinatol. 2021;41(2):324-329.
32. Cardenas VJ, Jr., Zwischenberger JB, Tao W, et al. Correction of
blood pH attenuates changes in hemodynamics and organ blood flow during
permissive hypercapnia. Crit Care Med. 1996;24(5):827-834.
33. Howell JH. Sodium Bicarbonate in the Perinantal
Settting—Revisited. Clinics in Perinatology.1987;14(4):807-816.
34. Isayama T, Chai-Adisaksopha C, McDonald SD. Noninvasive Ventilation
With vs Without Early Surfactant to Prevent Chronic Lung Disease in
Preterm Infants: A Systematic Review and Meta-analysis. JAMA
Pediatr. 2015;169(8):731-739.
35. Dargaville PA, Kamlin COF, Orsini F, et al. Effect of Minimally
Invasive Surfactant Therapy vs Sham Treatment on Death or
Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress
Syndrome: The OPTIMIST-A Randomized Clinical Trial. JAMA.2021;326(24):2478-2487.